Printer Friendly

Non-Invasive Glucose Monitoring Patent Landscape - The global glucose monitoring device market is estimated to reach $14 billion by 2019.

DUBLIN, Sept. 28, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Non-Invasive Glucose Monitoring Patent Landscape" report to their offering.

To this date, the conventional technique to measure glucose still involves drawing blood (finger pricking), which can cause pain and discomfort for the patient. Hence, the need to find a non-invasive technique to monitor glucose. Many companies have tried to develop non-invasive technology and device for glucose monitoring, but so far with no success.

A few devices had obtained approval from the authorities in the USA or Europe before being abandoned : GlucoWatch (Cygnus), Pendra (Pendragon Medical), NBM-200G (OrSense) or HG1-c (C8 MediSensors). Recently, Integrity Applications received the European CE Mark and launched its GlucoTrack DF-F device late 2014 in Europe. While several minimally-invasive devices are now commercially available, bringing to the market a totally non-invasive device would represent a great change for the market and the diabetics. The renewed IP interest for this topic observed recently shows the desire of players to overcome the same cause of failure faced in the last 3 decades, reliability and accuracy of the technology. The IP and the market for non-invasive monitoring of glucose are driven by the ever increasing diabetic population around the world as well as the recent sizeable democratization of wearable sensors for health monitoring. The spectrum of technologies investigated to monitor glucose non-invasively is very broad. Spectrometry is the most trendy technology. Spectrometry regroups various techniques, but they don't all receive the same focus. The spectrum of sample targets studied to perform a non-invasive measurement is also really broad. The detection of glucose level at the skin level or in the blood vessels are the most investigated. But techniques allowing a detection at the level of the eye are also considered and a new comer in the non-invasive glucose monitoring domain is investing mostly in this approach.Key Topics

1. Introduction

2. Executive Summary 3. IP Overview 4. Main Patent Litigations 5. Non-Invasive Devices for Glucose Monitoring 6. Key Players 7. Conclusions 8. AnnexCompanies Mentioned - Abbott - Animas Technologies - Bayer Healthcare - Cercacor - Futrex - Google - InLight Solutions - Integrity Applications - Key Player Selection - Masimo - OrSense - Panasonic - Roche Diagnostics - Samsung Electronics - Sensys Medical - Toshiba For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Date:Sep 28, 2015
Previous Article:Top 20 mPayment Companies in 2015.
Next Article:2020 India Smart Cities Infrastructure Investment Outlook.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters